Craniopharyngioma treatment often leads to severe hypothalamic obesity, profoundly impacting long-term prognosis and quality of life.
Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma.
Abstract
Childhood-onset craniopharyngioma treatment frequently causes severe hypothalamic obesity, leading to metabolic, cognitive, and psychosocial impairments, significantly reducing quality of life and increasing mortality risk.